Pholcodine OTCs Recalled In UK Following Sales Ban
The UK's Medicines and Healthcare products Regulatory Agency has recalled all OTC medicines containing pholcodine marketed in the country after deciding to ban their sale for safety reasons.
You may also be interested in...
National Regulators Back European Pholcodine Ban
By majority vote, the Heads of Medicines Agencies' CMDh has agreed to withdraw the marketing authorizations for all drugs containing pholcodine sold in the EU and European Economic Area countries.
People On The Move: Appointments At Orkla, PAGB, Afepadi
A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.
Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise
Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.